[Asia Economy Reporter Oh Su-yeon] Dongwon Industries announced on the 22nd that it has terminated the due diligence priority right granted on February 23rd through mutual agreement between the two companies regarding the acquisition of Boryung Biopharma.
Dongwon Industries stated that it has made the final decision not to proceed with the acquisition in this matter.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

